Vertex Pharmaceuticals Incorporated
Cash Flow Statement
| Line Item | FY2009 | FY2008 |
|---|---|---|
| Operating Activities | ||
| Net Income | $-642.2M | $-459.9M |
| Depreciation & Amortization | $30.1M | $32.2M |
| Depreciation | $28.3M | $30.4M |
| Amortization | — | — |
| Stock-Based Compensation | $86.7M | $58.0M |
| Net Cash from Operating Activities | $-427.6M | $-226.5M |
| Investing Activities | ||
| Capital Expenditures | $23.5M | $32.2M |
| Business Acquisitions | $87.4M | — |
| Net Cash from Investing Activities | $-508.7M | $-360.7M |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $999.0M | $620.7M |
| Net Change in Cash | $57.5M | $33.5M |
| Free Cash Flow | $-451.1M | $-258.7M |